Month: January 2024

The John Lennon Educational Tour Bus Powered by Battle Born Batteries at the 2024 NAMM ShowThe John Lennon Educational Tour Bus Powered by Battle Born Batteries at the 2024 NAMM ShowThe John Lennon Educational Tour Bus is now powered by Battle Born Batteries’ nontoxic lithium batteries, moving the nonprofit mobile recording studio toward improved sustainability. The move to lithium batteries and solar panels allows the nonprofit to enhance their student experiences, increase the organization’s reach, and save money on expensive generator fuel as they share music education across the country. Dragonfly Energy uses sixteen 270Ah 12V Battle Born LiFePO4 deep cycle batteries plus twelve 200W solar panels to power the mobile recording studio off the grid for up to eight hours of runtime with no loud generators. This runtime greatly...

Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company”) is pleased to announce it has received final approval from the TMX Venture Exchange (the “Exchange”) of the non-brokered private placement (the “Offering”) announced on December 8th, 2023. This financing was fully closed effective December 31st, 2023, with conditional approval from the Exchange. Sparton has issued a total of 11,500,000 Flow-Through Share (“FTS”) Units of the Company (each, a FTS Unit”) at a price of C$0.05 per FTS Unit. Each FTS Unit consists of one common share of the Company and a ½ (one half) non-flow through Share Purchase Warrant (“SPW”) for a total of 5,500,000 Full SPWs. These include the Finder Warrants...

85 patients enrolled TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. Enrollment:Robust enrollment activity continued throughout January 2024:85 patients enrolled to-date Four patients enrolled in the month of JanuaryClosing in on the interim enrollment target of 90 patients (“Interim Enrollment”); at Interim Enrollment, Baxter has the option to make the second milestone payment to Spectral to maintain its PMX exclusive distribution rights.Trial Sites:Continue...

Shelton, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) — Exhibit 99.1 HUBBELL REPORTS FOURTH QUARTER 2023 AND FULL YEAR RESULTSQ4 diluted EPS from continuing operations of $3.16; adjusted diluted EPS from continuing operations of $3.69 Q4 net sales from continuing operations +10% (organic +8%) FY 2023 diluted EPS from continuing operations of $14.05; adjusted diluted EPS from continuing operations of $15.33 FY 2024 diluted EPS from continuing operations expected range of $14.40-$14.90; adjusted diluted EPS from continuing operations expected range of $16.00-$16.50SHELTON, CT. (January 30, 2024) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter and full year ended December 31, 2023. “Hubbell delivered a strong finish to a strong year,” said Gerben Bakker, Chairman, President and CEO. “For the full...

The first THC containing pharmaceutical preparations produced in Brazil approved by the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria, “ANVISA”) TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce ANVISA has granted commercialization approval of Ease Labs Pharma (“Ease Labs”) pharmaceutical preparation produced in Brazil containing Avicanna’s Aureus branded active pharmaceutical ingredient (“API”). Ease Labs, a GMP-certified pharmaceutical company in Brazil, was granted approval from ANVISA to commercialize a pharmaceutical preparation product containing 2.5% of CBD and...

VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF) (“AEMC” or the “Company”) is pleased to provide a corporate update that highlights the accomplishments made since inception in April 2023 and looks ahead to 2024 plans.             Alaska Energy Metals Corporation President & CEO Gregory Beischer commented: “I am very proud of what we have accomplished in just 10 months. We’ve successfully rebranded and recapitalized the Company; no small feat given challenging market conditions. For our Nikolai Nickel project in Alaska, we purchased a large database of historical information, calculated a significant maiden nickel resource, and identified drill targets to test for high-grade mineralization. With all our 2023 drill results now in hand, we will soon publish...

KUALA LUMPUR, Malaysia, Jan. 30, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, or the “Company”) is awarded an initial public offering (“IPO”) contract to list one of the largest Information Technology companies in Malaysia (“IT Company”), providing cutting-edge cross-border technology solutions and services. A Memorandum of Understanding (“MOU”) was inked yesterday between VCI Global and Legacy Corporate Advisory Sdn Bhd (“Legacy Corporate Advisory”), solidifying their commitment to establishing a strategic alliance. This collaborative venture reflects a dedication to mutual cooperation, leveraging respective strengths and resources, and jointly exploring new market opportunities, particularly in relation to IPOs on stock exchanges in the United States. This partnership has resulted in their first IPO...